SNC
NPSP

Stifel Nicolaus & Co’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Stifel Nicolaus & Co’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$6.06M Sell
190,411
-196,978
-51% -$4.52M 0.1% 204
2013
Q2 		$5.85M Buy
+387,389
New +$5.37M 0.11% 189

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Nicolaus & Co's NPSP Position: Q3 2013 in Review

Stifel Nicolaus & Co reduced its NPS PHARMACEUTICALS INC (NPSP) stake by 51% in Q3 2013, selling an estimated $4.52M and leaving 190,411 shares worth $6.06M. The position accounts for 0.1% of the portfolio, ranked #204.

Stifel Nicolaus & Co first reported a position in NPSP in Q2 2013 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold NPSP as of Q3 2013.

  • Stifel Nicolaus & Co held 190,411 shares of NPS PHARMACEUTICALS INC worth $6.06M as of Q3 2013.
  • Stifel Nicolaus & Co sold 196,978 NPS PHARMACEUTICALS INC shares in Q3 2013, an estimated $4.52M.
  • NPS PHARMACEUTICALS INC made up 0.1% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #204 holding.
  • Stifel Nicolaus & Co first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.